Back to search
Hyper-low-density Lipoprotein (LDL) Cholesterolemia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hyper-low-density Lipoprotein (LDL) Cholesterolemia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hyper-low-density Lipoprotein (LDL) Cholesterolemia trials you may qualify forA Multicenter, Open-label Study to assess the safety and efficacy of ETC-1002 at 180 mg administered for 52 weeks in patients with hyper-LDL cholesterolemia
The purpose of this study is to confirm the superiority of ETC-1002 after 12 weeks of administration at 180 mg/day to placebo in patients with hyper-LDL cholest…